The outcomes of clinical cases and analysis of the cBioPortal for Cancer Genomics database also demonstrated the significant positive correlation among RUNX2, BRG1, and CD44 expressions in colon cancer tissues. Here, CD44 is linked to malignant colon neoplasm.